MedTrace Logo

Prognostic Role of Free Psa Ratio at Biochemical Recurrence After Radical Treatments for Prostate Cancer

NCT03927287 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 822

Last updated 2019-04-25

No results posted yet for this study

Summary

Measurement of Free PSA ratio in patients after definitive radical treatment for prostate cancer, and assessment of whether post-treatment free PSA ratio can function as a biomarker for advanced disease in prostate cancer patients.

Conditions

  • Metastasis
  • Castration-resistant Prostate Cancer
  • Death

Interventions

DIAGNOSTIC_TEST

Free PSA ratio test in patients after definitive treatment for localized prostate cancer

Free PSA ratio blood test done on biobank samples of patients after radical prostatectomy who developed biochemical recurrence.

Sponsors & Collaborators

  • University of Toronto

    collaborator OTHER

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Neil Fleshner, MD, MPH · Princess Margaret Hospital, University Health Network

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-12-30
Completion
2019-04-10

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03927287 on ClinicalTrials.gov